- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01759368
Heart at Home- a Self-care Study
15 septembre 2014 mis à jour par: VTT Technical Research Centre of Finland
Heart at Home- Remote Patient Monitoring in the Care of Heart Failure Patients
In the study benefits of using mobile phone assisted remote patient monitoring including self-measurements of blood pressure, heart rate and weight as well as monitoring of personal health status are investigated in the care of heart failure patients.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Réel)
94
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Espoo, Finlande
- VTT Technical Research Centre of Finland
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans à 90 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- diagnosis of systolic heart failure
- NYHA (New York Heart Association) classification > 1
- left ventricular ejection fraction ≤ 35%
- need for a regular control visit
- time from the last visit no longer than 6 months
Exclusion Criteria:
- Patients who were known to enter a major medical operation
- severe comorbidity,
- participation in other clinical trial during last three months-
- poor compliance in terms of familiarity with mobile phone
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Telemonitoring assisted self-care
Telemonitoring group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions.
The measurements taken at home to be uploaded were: diastolic and systolic blood pressure, pulse, body weight and an assessment of symptoms.
The symptom assessment concerned the patient's feelings of dizziness, dyspnea, palpitation, weakness and, oedema.
Patients were also asked to evaluate their overall condition- whether their condition had deteriorated, improved or remained unchanged.
The patients were advised to carry out and report the measurements together with the self-assessment once a week.
The responsible nurse followed patients' status and the data once a week or more frequently if needed.
Based on the reported measurements, the nurse could invite the patient for a control visit.
In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
|
Telemonitoring group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions.
The measurements taken at home to be uploaded were: diastolic and systolic blood pressure, pulse, body weight and an assessment of symptoms.
The symptom assessment concerned the patient's feelings of dizziness, dyspnea, palpitation, weakness and, oedema.
Patients were also asked to evaluate their overall condition- whether their condition had deteriorated, improved or remained unchanged.
The patients were advised to carry out and report the measurements together with the self-assessment once a week.
The responsible nurse followed patients' status and the data once a week or more frequently if needed.
Based on the reported measurements, the nurse could invite the patient for a control visit.
In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring
|
|
Aucune intervention: Control group
Control group received usual care that includes multidisciplinary care approach in which patients receive guidance and support for self-care.
In the care of heart failure (HF) patients, the cardiac team plays a central role in monitoring and interpreting patient symptoms, optimizing medication and providing education.
The cardiac team consists of two physicians, one specialized heart failure nurse and a physiotherapist who helps after a hospitalization period.
As part of the care process, patients capable of carrying out self-care are identified and they are encouraged to regularly measure their blood pressure, heart rate and weight at home.
So far, the information exchange between heart failure patients and care personnel has taken place during patients' visits to the clinic and by telephone.
Systematic collection and exploitation of the self-measurement data has been difficult, since it depends on the patient's own activity
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of HF-related Hospital Days
Délai: From baseline until the end of the study at six months
|
Number of heart failure related hospital days
|
From baseline until the end of the study at six months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Death
Délai: From baseline until the end of the study at six months
|
Death from any cause
|
From baseline until the end of the study at six months
|
|
Heart Transplant
Délai: From baseline until the end of the study at six months
|
Heart transplant operation or listing for transplant operation
|
From baseline until the end of the study at six months
|
|
P-proBNP
Délai: From baseline until the end of the study at six months
|
Change in plasma concentration of brain natriuretic peptide propeptide from baseline to the end of the study.
|
From baseline until the end of the study at six months
|
|
EHFSBS (European Heart Failure Self-Care Behaviour Scale ) Scores
Délai: From baseline until the end of the study at six months
|
Change in self-care behaviour measured by the European Heart Failure Self-Care Behaviour Scale (EHFSBS).
EHFSBS is a 12-item self-administered questionnaire specifically designed and tested for heart failure patients including statements on self-care behaviour essential in the care of HF.
The statements are scored from one to five.
The lower the score, the better the performance in self-care.
The summary score is analysed.
|
From baseline until the end of the study at six months
|
|
Left Ventricular Ejection Fraction
Délai: From baseline until the end of the study at six months
|
Change in left ventricular ejection fraction from baseline until the end of the study
|
From baseline until the end of the study at six months
|
|
Utilization of Health Care Resources
Délai: From baseline until the end of the study at six months
|
Number of visits to nurse's reception
|
From baseline until the end of the study at six months
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Plasma Concentrations of Creatinine, Natrium, and Potassium From the Baseline to the End of the Study
Délai: From baseline to the end of the study at six months
|
Change in plasma concentrations of creatinine, natrium, and potassium
|
From baseline to the end of the study at six months
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 octobre 2010
Achèvement primaire (Réel)
1 mars 2012
Achèvement de l'étude (Réel)
1 juin 2012
Dates d'inscription aux études
Première soumission
20 décembre 2012
Première soumission répondant aux critères de contrôle qualité
30 décembre 2012
Première publication (Estimation)
3 janvier 2013
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
17 septembre 2014
Dernière mise à jour soumise répondant aux critères de contrôle qualité
15 septembre 2014
Dernière vérification
1 septembre 2014
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- HUSHAH
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .